This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CVS/pharmacy To Help Patients Save Time And Money During Annual Medicare Part D Enrollment Period

WOONSOCKET, R.I., Oct. 15, 2013 /PRNewswire/ -- CVS/pharmacy, the retail division of CVS Caremark (NYSE: CVS), announced today that it will offer its senior patients a new and easy way to compare Medicare Part D prescription drug plans when the Annual Enrollment Period begins today, October 15 to December 7, 2013.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO )

All CVS/pharmacy locations nationwide will be able to create and print a Medicare Part D plan comparison in minutes for patients based on the current prescriptions they fill at CVS. In addition, patients who wish to conduct their plan comparison online or on the phone will receive their own personal code from CVS/pharmacy that they can enter at www.cvs.com/medicare or by calling CVS at 1-877-543-6656. Once entered, the personal code will automatically insert patients' current prescriptions to provide a personalized plan comparison in just minutes. 

Annual Enrollment is the one time a year that most Medicare beneficiaries can review their current prescription coverage and enroll in a new plan for 2014 if they so choose. Because Medicare Part D plans change every year and people's prescription needs may also change, comparing Part D plans could save patients hundreds of dollars. 

Whether changing Medicare Part D plans or choosing one for the first time, it is important for patients to consider their annual deductible, premium and co-payments, whether all prescriptions they are taking are covered, out-of-pocket expenses, and whether their pharmacy is included in the plan.

"CVS/pharmacy's new plan comparison system provides patients with convenient ways to learn how much money they could save by choosing a new Medicare Part D plan based on their own prescription usage," said Papatya Tankut, RPh, Vice President of Pharmacy Affairs, CVS/pharmacy. "While pharmacists cannot recommend any specific Medicare Part D plan, we can help patients understand their options based on their individual needs."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,534.09 -108.92 -0.65%
S&P 500 1,971.76 -17.11 -0.86%
NASDAQ 4,779.8780 -48.4470 -1.00%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs